Matches in Wikidata for { <http://www.wikidata.org/entity/Q64151674> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q64151674 description "clinical trial" @default.
- Q64151674 description "ensayu clínicu" @default.
- Q64151674 description "klinisch onderzoek" @default.
- Q64151674 description "клінічне випробування" @default.
- Q64151674 description "կլինիկական փորձարկում" @default.
- Q64151674 name "Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type" @default.
- Q64151674 type Item @default.
- Q64151674 label "Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type" @default.
- Q64151674 prefLabel "Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type" @default.
- Q64151674 P1050 Q64151674-1B2E5036-9F25-4F44-909F-49F9945A8A3F @default.
- Q64151674 P1050 Q64151674-B4E5DA47-ECAD-49AE-B246-ED71619EF19C @default.
- Q64151674 P1132 Q64151674-879B21FA-21D8-42DA-9EA8-41E15FC5F397 @default.
- Q64151674 P1476 Q64151674-968F65FF-6482-4A62-8693-CB0B7F128CBE @default.
- Q64151674 P17 Q64151674-263D5AA5-F13C-4FD7-86A2-8733ADFB3543 @default.
- Q64151674 P17 Q64151674-2D04C43E-B1D5-4D61-8F25-1F864FDB6651 @default.
- Q64151674 P2899 Q64151674-48F6DDC0-220C-4921-89EF-2D9E774DB351 @default.
- Q64151674 P3098 Q64151674-F5100B8B-A362-4E38-8693-D07863D88F3B @default.
- Q64151674 P31 Q64151674-58FC1955-8D6A-48D6-8C2D-B14895A09AA2 @default.
- Q64151674 P4135 Q64151674-5A79BB32-2E83-4AE7-9172-C9FD997311DD @default.
- Q64151674 P580 Q64151674-46E70850-9A63-4736-ACCF-074AA1ADE029 @default.
- Q64151674 P582 Q64151674-51C4F135-4A6E-497D-A680-1C51FC11BB28 @default.
- Q64151674 P6099 Q64151674-E1D729A7-678F-4F87-B5E3-9F7FC40C01D8 @default.
- Q64151674 P6153 Q64151674-59EA873A-C2C5-49E4-9E0C-DC89BF2218AB @default.
- Q64151674 P6153 Q64151674-7BCFC898-7645-4774-8DE8-994AA0232258 @default.
- Q64151674 P6153 Q64151674-836A11C7-3C85-4483-ADF3-846C60B83B1A @default.
- Q64151674 P6153 Q64151674-9226C4EB-4333-4BA5-B24E-E3772477EA8E @default.
- Q64151674 P6153 Q64151674-ABEA976C-D522-4521-ABF6-2D2FAEA1FE1C @default.
- Q64151674 P6153 Q64151674-AD5F483B-544B-4E86-A736-7478B9C8BBA9 @default.
- Q64151674 P6153 Q64151674-C7C7C5FB-86CB-45E7-A2B1-21A6EA1E3E21 @default.
- Q64151674 P8363 Q64151674-DFD1080F-7C4C-4F22-A0CF-34D6C744FDFE @default.
- Q64151674 P1050 Q394129 @default.
- Q64151674 P1050 Q83030 @default.
- Q64151674 P1132 "+522" @default.
- Q64151674 P1476 "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type." @default.
- Q64151674 P17 Q16 @default.
- Q64151674 P17 Q30 @default.
- Q64151674 P2899 "+50" @default.
- Q64151674 P3098 "NCT02442778" @default.
- Q64151674 P31 Q30612 @default.
- Q64151674 P4135 "+90" @default.
- Q64151674 P580 "2015-09-01T00:00:00Z" @default.
- Q64151674 P582 "2019-09-01T00:00:00Z" @default.
- Q64151674 P6099 Q42824827 @default.
- Q64151674 P6153 Q2471216 @default.
- Q64151674 P6153 Q270222 @default.
- Q64151674 P6153 Q2892284 @default.
- Q64151674 P6153 Q30269704 @default.
- Q64151674 P6153 Q30269718 @default.
- Q64151674 P6153 Q4998956 @default.
- Q64151674 P6153 Q50036718 @default.
- Q64151674 P8363 Q78089383 @default.